Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Plows Out: Telecommuting Triumphs As Blizzard Puts A Hole In CDER's Roof

Executive Summary

PDUFA user fee dates could slip by as much as five business days because of the blizzards that shut down the federal government in Washington, D.C., Feb. 8-11

Related Content

Shutdown Week Two: Could Sponsors Find A More Focused FDA?
Hurricane Sandy Rains On User Fee Dates, Advisory Committees
Pharma Responds To Sandy’s Wrath With Delays
Pixuvri And Omapro Will Get Tight Reviews After Rescheduled Committee Meeting
Prospects For GSK/XenoPort's Horizant Sink After Rejection By FDA
ESA REMS Allows Oncology Providers One Year To Enroll Before Possible Distribution Limits
Crestor Label Lends Validity To Controversial C-Reactive Protein Test
ChemGenex's Omapro Faces Scaled Back Efficacy Claims After Trial Shortcomings
Snow banks FDA's user fee deadlines
Snow banks FDA's user fee deadlines





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts